Gevo insider plans sale of 39,957 shares

Gevo, Inc. insider Christopher Ryan has filed to sell up to 39,957 shares of common stock through Stifel Nicolaus & Company on the Nasdaq on or after August 6, 2026, with an indicated aggregate market value of $61,765.53 for the planned sale.

Rhea-AI Filing Summary

Gevo, Inc. insider Christopher Ryan has filed to sell up to 39,957 shares of common stock through Stifel Nicolaus & Company on the Nasdaq on or after August 6, 2026, with an indicated aggregate market value of $61,765.53 for the planned sale.

The filing references 88,740 shares of common stock acquired as Restricted Stock Awards on August 3, 2023 as equity compensation. It also lists recent sales by Ryan of 87,700 shares for $154,334.00 on May 27, 2026 and 35,196 shares for $50,161.00 on June 12, 2026, and notes 243,411,329 shares of Gevo common stock outstanding.

Key Figures

Planned shares to be sold: 39,957 shares Aggregate market value of planned sale: $61,765.53 Shares acquired as Restricted Stock Awards: 88,740 shares +3 more

6 metrics

Planned shares to be sold 39,957 shares Common stock to be sold through Stifel Nicolaus & Company on or after August 6, 2026

Aggregate market value of planned sale $61,765.53 Indicated aggregate market value for 39,957 shares of common stock

Shares acquired as Restricted Stock Awards 88,740 shares Common stock received as Restricted Stock Awards on August 3, 2023 as equity compensation

Recent sale on May 27, 2026 87,700 shares for $154,334.00 Common stock sold during the past 3 months

Recent sale on June 12, 2026 35,196 shares for $50,161.00 Common stock sold during the past 3 months

Shares outstanding 243,411,329 shares Gevo common stock outstanding cited in connection with the planned sale

Key Terms

Form 144, Restricted Stock Awards, Equity Compensation

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Awards financial

"Common Stock | 08/03/2023 | Restricted Stock Awards | Issuer"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

Equity Compensation financial

"88740 | 08/06/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the GEVO Form 144 filing by Christopher Ryan disclose?

The filing shows Christopher Ryan plans to sell up to 39,957 GEVO shares through Stifel on Nasdaq, with an indicated market value of $61,765.53. It also details prior sales and equity compensation-related Restricted Stock Awards.

How many GEVO shares is Christopher Ryan planning to sell under this notice?

Christopher Ryan plans to sell up to 39,957 shares of GEVO common stock. The planned transaction has an indicated aggregate market value of $61,765.53 and is expected to be executed through Stifel Nicolaus & Company on Nasdaq.

What recent GEVO share sales by Christopher Ryan are reported in this Form 144?

The notice reports Ryan sold 87,700 GEVO shares for $154,334.00 on May 27, 2026 and 35,196 shares for $50,161.00 on June 12, 2026. These transactions occurred in the three months preceding the new planned sale.

What equity compensation information for GEVO is included in Christopher Ryan’s filing?

The filing notes Ryan received 88,740 GEVO common shares as Restricted Stock Awards on August 3, 2023 as equity compensation. This award is cited as the source of some of the shares referenced in the planned and prior sales.

How many GEVO shares are outstanding according to this Form 144 filing?

The filing cites 243,411,329 GEVO common shares outstanding as a reference figure. This number provides context for the size of Christopher Ryan’s planned and recent sales relative to the company’s total common stock base.

Which broker and market are involved in the planned GEVO stock sale?

The planned sale of 39,957 GEVO shares will be handled by Stifel Nicolaus & Company Inc. with trading on the Nasdaq market. The indicated date for this planned transaction is August 6, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 04:21 PM Accepted by SEC EDGAR 08/06/2026 - 04:21 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001512143
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Gevo, Inc.
SEC File Number	001-35073
Address of Issuer	345 INVERNESS DRIVE SOUTH, BUILDING C Suite 310 ENGLEWOOD COLORADO 80112
Phone	303-858-8358
Name of Person for Whose Account the Securities are To Be Sold	Ryan Christopher Michael
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	39957	61765.53	243411329	08/06/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/03/2023	Restricted Stock Awards	Issuer			88740	08/06/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher Ryan 345 INVERNESS DR. SOUTH BUILDING C SUITE 310 ENGLEWOOD CO 80112	Common Stock	05/27/2026	87700	154334.00
Christopher Ryan 345 INVERNESS DR. SOUTH BUILDING C SUITE 310 ENGLEWOOD CO 80112	Common Stock	06/12/2026	35196	50161.00

144: Remarks and Signature

Remarks
Date of Notice	08/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Christopher Ryan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)